Valuation: Clover Corporation Limited

Market Cap 125M 87.21M 76.29M 70.36M 64.99M 123M 8.32B 841M 330M 4.1B 327M 320M 14.09B P/E 2024
54x
P/E 2025 13.2x
Enterprise Value 119M 82.86M 72.48M 66.85M 61.74M 117M 7.9B 799M 314M 3.89B 311M 304M 13.38B EV / Sales 2024
1.29x
EV / Sales 2025 1x
Free-Float
81.18%
Yield 2024
1.53%
Yield 2025 3.15%
1 day-0.66%
1 week+1.34%
Current month-10.65%
1 month-11.18%
3 months-24.50%
6 months-5.03%
Current year-4.43%
1 week 0.7
Extreme 0.7
0.76
1 month 0.7
Extreme 0.7
0.9
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.515
1.16
3 years 0.34
Extreme 0.337
1.22
5 years 0.34
Extreme 0.337
1.88
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 10/11/2014
Director of Finance/CFO - 05/05/2021
Chief Operating Officer - 02/02/2011
Director TitleAgeSince
Director/Board Member - 10/11/2014
Chairman - 20/09/2017
Director/Board Member - 31/01/2017
Date Insider Type Main position Quantity % Market Cap.
11-17Sell

Chief Executive Officer

255,199 0.1528%
11-17Buy

Chief Executive Officer

529,638 0.3171%
11-05Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%+1.34%+45.19%-37.60% 87.21M
+0.03%-4.33%+31.53%+83.15% 13B
+6.38%+5.42%-23.85%+269.45% 7.95B
+2.31%-0.43%-19.67%-55.43% 2.3B
+2.62%-4.45% - - 1.46B
+2.72%-9.96%-78.46%-64.24% 1.45B
+1.94%+0.31%+29.17%+6.13% 1.36B
+0.37%-3.25%-30.89%-26.91% 1.23B
+1.38%-0.50%+20.28%+47.53% 1.23B
-1.84%-6.99%-61.17%-64.94% 1.13B
Average +1.52%-2.28%-9.76%+17.46% 3.12B
Weighted average by Cap. +2.14%-2.72%+0.76%+99.50%

Financials

2024 2025
Net sales 62.21M 43.27M 37.85M 34.91M 32.24M 61.18M 4.13B 417M 164M 2.03B 162M 159M 6.99B 86M 59.82M 52.33M 48.26M 44.58M 84.58M 5.71B 577M 226M 2.81B 225M 220M 9.66B
Net income 1.52M 1.05M 922K 850K 785K 1.49M 101M 10.16M 3.99M 49.51M 3.96M 3.87M 170M 7.02M 4.88M 4.27M 3.94M 3.64M 6.9M 465M 47.04M 18.47M 229M 18.32M 17.92M 788M
Net Debt -1.87M -1.3M -1.14M -1.05M -970K -1.84M -124M -12.55M -4.93M -61.18M -4.89M -4.78M -210M -6.26M -4.35M -3.81M -3.51M -3.25M -6.16M -415M -41.98M -16.49M -205M -16.35M -16M -703M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
10/07/26 A$0.7550 -0.66% 12,038
09/07/26 A$0.7600 -0.65% 2,677
08/07/26 A$0.7650 +1.32% 439,128
07/07/26 A$0.7550 -1.31% 9,913
06/07/26 A$0.7650 +2.68% 249,820
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB

Annual profits - Rate of surprise